ADXS - 1.22 Pre-market now at 1.97/1.98 Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab http://stockcharts.com/c-sc/sc?s=ADXS&p=D&b=5&g=0&i=t39912309292&r=1531483297129